These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5910152)

  • 1. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid.
    Kellermeyer RW; Breckenridge RT
    J Lab Clin Med; 1966 Mar; 67(3):455-60. PubMed ID: 5910152
    [No Abstract]   [Full Text] [Related]  

  • 2. Classic gout in Hageman factor (Factor XII) deficiency.
    Green D; Arsever CL; Grumet KA; Ratnoff OD
    Arch Intern Med; 1982 Aug; 142(8):1556-7. PubMed ID: 7103639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory process in acute gouty arthritis. 3. Vascular permeability-enhancing activity in normal human synovial fluid; induction by Hageman factor activators; and inhibition by Hageman factor antiserum.
    Kellermeyer RW
    J Lab Clin Med; 1967 Sep; 70(3):372-83. PubMed ID: 6038543
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synovial inflammation and coagulation factors. II. Biological study of synovial fluid in serogically positive rheumatoid arthritis].
    Soria C; Guérin B; Larrieu MJ; Caen J; Kahn MF; Girard ML
    Pathol Biol (Paris); 1972 Sep; 20(15):695-701. PubMed ID: 4116649
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 6. Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent.
    Haanen C; Morselt G; Schoenmakers J
    Thromb Diath Haemorrh; 1967 May; 17(3-4):307-20. PubMed ID: 5626768
    [No Abstract]   [Full Text] [Related]  

  • 7. THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS.
    KELLERMEYER RW; BRECKENRIDGE RT
    J Lab Clin Med; 1965 Feb; 65():307-15. PubMed ID: 14267254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of coagulation factors in normal and pathological synovial fluids. Demonstration of a special coagulation factor in certain synovial fluids in rheumatoid arthritis].
    Guérin B; Soria C; Kahn MF; de Sèze S
    Rev Rhum Mal Osteoartic; 1972 Oct; 39(10):581-7. PubMed ID: 5083694
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 10. Hageman factor (factor XII) activity in synovial fluid of rheumatoid arthritis patients and its possible pathogenic significance.
    Szpilmanowa H; Stachurska J
    Experientia; 1968 Aug; 24(8):784-5. PubMed ID: 5683163
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
    Forbes CD; Pensky J; Ratnoff OD
    J Lab Clin Med; 1970 Nov; 76(5):809-15. PubMed ID: 5477337
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
    RATNOFF OD; DAVIE EW; MALLETT DL
    J Clin Invest; 1961 May; 40(5):803-19. PubMed ID: 13739760
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective study of morphology and phagocytosis of synovial fluid monosodium urate crystals in gouty arthritis.
    Antommattei O; Schumacher HR; Reginato AJ; Clayburne G
    J Rheumatol; 1984 Dec; 11(6):741-4. PubMed ID: 6520827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contact phase of coagulation in the presence of heparin.
    BLOOM AL
    J Clin Pathol; 1962 Nov; 15(6):508-10. PubMed ID: 13971779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood coagulation factors and articular inflammation].
    Guérin B; Kahn MF
    Rev Rhum Mal Osteoartic; 1970 Apr; 37(4):335-46. PubMed ID: 5421594
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity of the contact substance in thromboplastin formation in the full-term newborn infant].
    Schettini F; Wierdis T; Lattanzi E; Violante N; Zimbalatti F
    Boll Soc Ital Biol Sper; 1966 Aug; 42(16):1058-60. PubMed ID: 5969468
    [No Abstract]   [Full Text] [Related]  

  • 17. [The activity of the contact substance in thromboplastin formation in the premature infant].
    Schettini F; Violante N; Lattanzi E; Mautone A
    Boll Soc Ital Biol Sper; 1966 Aug; 42(16):1060-3. PubMed ID: 5969469
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synovial fluid analysis in gout].
    Mader R
    Harefuah; 1998 Dec; 135(11):555-7. PubMed ID: 10911478
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synovial inflammation and coagulation factors. I. General study].
    Guérin B; Soria C; Larrieu MJ; Caen J; Kahn MF; Girard ML; Solnica J
    Pathol Biol (Paris); 1972 Sep; 20(15):689-94. PubMed ID: 4562042
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma.
    SCHIFFMAN S; RAPAPORT SI; WARE AG; MEHL JW
    Proc Soc Exp Biol Med; 1960 Dec; 105():453-5. PubMed ID: 13747627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.